INCEPTION
LIVE

Serial Number

98842210

Owner

Inception Therapeutics, Inc.

Attorney

Aaron D. Hendelman

Filing Date

Nov 7, 2024

Add to watchlist:

No watchlists yet
View on USPTO

INCEPTION Trademark

Serial Number: 98842210

INCEPTION is a trademark filed by Inception Therapeutics, Inc. on November 7, 2024. The trademark is classified under Class 36 (Insurance & Financial), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Inception Therapeutics, Inc.

6175 Nancy Ridge Dr.
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

November 7, 2024

Registration Date

Not Registered

Goods & Services

Incubation services, namely, providing business support consulting services to emerging and start-up companies in the life sciences industry; market research and business marketing consulting services in the life sciences industry; market analysis; collection of market research information; providing business intelligence services in the field of life sciences; assistance, advisory services, and consultancy with regard to business planning, business analysis, business management, business organization, marketing, and customer analysis; business advisory services, consultancy and information services in the field of life sciences; business consulting services, business services, namely, providing assistance in development of business strategies and product ideation, business services, namely, matching, identifying and securing investors with entrepreneurs needing funding, and consultancy and advisory services in the field of business strategy, all of the forgoing to emerging and start-up life science companies; none of the foregoing related to clinical trials, clinical research, applications for drug approval, or branding services

Incubation services, namely, providing financing to emerging and start-up companies in the life science industry; venture capital funding services to emerging and start-up life sciences companies; providing working capital financing to emerging and start-up life sciences companies; venture capital financing; none of the foregoing related to clinical trials, clinical research, or applications for drug approval

Filing History

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 7, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 7, 2025 GNSL
SUSPENSION LETTER WRITTEN
Nov 7, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 14, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 9, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 9, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 10, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 10, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 9, 2025 GNRN
NON-FINAL ACTION E-MAILED
Apr 9, 2025 GNRT
NON-FINAL ACTION WRITTEN
Apr 9, 2025 CNRT
ASSIGNED TO EXAMINER
Apr 2, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 7, 2024 NWOS
NEW APPLICATION ENTERED
Nov 7, 2024 NWAP